Cargando…
Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting
OBJECTIVES: To evaluate the real-world association between varenicline and neuropsychiatric adverse events (NPAEs) in general and chronic obstructive pulmonary disease (COPD) population with and without psychiatric disorders compared with nicotine replacement therapy (NRT) to strengthen the knowledg...
Autores principales: | Wang, Yuanyuan, Bos, Jens H., Schuiling-Veninga, Catharina C.M., Boezen, H. Marike, van Boven, Job F. M., Wilffert, Bob, Hak, Eelko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154988/ https://www.ncbi.nlm.nih.gov/pubmed/34035088 http://dx.doi.org/10.1136/bmjopen-2020-042417 |
Ejemplares similares
-
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis
por: Wang, Yuanyuan, et al.
Publicado: (2021) -
Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study
por: Wang, Yuanyuan, et al.
Publicado: (2020) -
Does smoking cessation with varenicline worsen vascular endothelial function?
por: Umeda, Akira, et al.
Publicado: (2013) -
What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
por: Davies, Neil M, et al.
Publicado: (2015) -
Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records
por: Itani, Taha, et al.
Publicado: (2019)